Increased autoantibodies to SOX13 in Swedish patients with type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 958, Issue , 2002, Pages 218-223

  Torn C ^a,c   Shtauvere Brameus, A ^b   Sanjeevi, C B ^b   Landin Olsson, M ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c BMC 221 84 Lund Sweden   (Sweden)

Author keywords

Autoimmune; GADA; IA 2A; ICA; Sensitivity

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; IA ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; SOX13 ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX13; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AUTOIMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PATHOGENESIS; PREVALENCE; RADIOIMMUNOPRECIPITATION; SCHOOL CHILD; SWEDEN;

EID: 0036271306     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb02973.x     Document Type: Conference Paper

References (17)

1. IA-2 antibodies: A sensitive marker of IDDM with clinical onset in childhood and adolescence
2. Cloning and expression of IDDM-specific human autoantigens
3. Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets
4. Genetic evidence equating SRY and the testis-determining factor
5. Male development of chromosomally female mice transgenic for Sry
6. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos
7. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4
8. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9
9. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model
10. SOX10 mutations in patients with Waardenburg-Hirschburg disease
11. Autoantibodies to ICA12 (SOX13) are not specific for Type 1 diabetes
12. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus
13. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes
14. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
15. Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands
16. ICA512 autoantibody radioassay